Nintedanib Esilate Soft Capsules Market: How Is Inhalation...

adicionou um novo artigo Health

2026-07-16 10:21:57 -

Nintedanib Esilate Soft Capsules Market: How Is Inhalation Formulation Innovation Redefining Antifibrotic Drug Delivery?

Nintedanib esilate soft capsules — the oral tyrosine kinase inhibitor formulation (Ofev, Boehringer Ingelheim) targeting PDGFR, FGFR, and VEGFR to inhibit fibroblast proliferation and migration, approved for idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and progressive fibrosing ILD — represent the cornerstone of antifibrotic...

0 Comentários 0 Compartilhamentos 40 Visualizações 0 Anterior